Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Impedimed Ltd Ord (IPDQF)

Impedimed Ltd Ord (IPDQF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ImpediMed Limited Announces Details for Upcoming Online AGM

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Impedimed...

IPDQF : 0.0140 (-17.65%)
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), Impedimed Limited (OtherIPDQF) and Humana (HUM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Apellis Pharmaceuticals (APLS – Research Report), Impedimed Limited (IPDQF – Research Report) and Humana (HUM – Research...

HUM : 185.25 (-2.78%)
APLS : 20.37 (-2.81%)
IPDQF : 0.0140 (-17.65%)
Impedimed Limited Announces Cessation of Securities

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement...

IPDQF : 0.0140 (-17.65%)
Impedimed Limited Issues 17.25 Million Unquoted Equity Securities

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

IPDQF : 0.0140 (-17.65%)
Canaccord Genuity Reaffirms Their Buy Rating on Impedimed Limited (IPDQF)

In a report released on October 3, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Impedimed Limited, with a price target of A$0.07. The company’s shares closed last Friday at $0.03.Elevate...

IPDQF : 0.0140 (-17.65%)
ImpediMed Gains Major US Insurance Coverage for Lymphedema Assessment

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

IPDQF : 0.0140 (-17.65%)

Barchart Exclusives

Nvidia Stock Forecast: Could NVDA Stock Rise To $300 in 2026?
Nvidia's stock fell after its fiscal Q4 2026 earnings release. Can NVDA stock rise to $300 as many analysts predict? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar